By proceeding, you agree to our Terms of Use and Privacy Policy.
The mRNA Quality Control & Comparability Summit aims to address the lack of knowledge and standardization in the evaluation of mRNA therapeutics and vaccines. The current methods used are difficult to compare and standardize, and there is a need for common understanding and regulations in analytical procedures to assess the quality of mRNA-based products.This summit provides a platform for industry experts to discuss strategies for ensuring quality and consistency of mRNA-based products throughout their lifecycle, including testing raw materials, assessing stability, potency, and purity, and managing the product lifecycle. Attendees can learn from case studies and experiences shared by leading industry players.
Understand the key developments and advancements in mRNA medicines.
Explore the latest advancements in overcoming purification challenges for mRNA product development to create a successful and purified mRNA medicine.
Delve into the analytical comparability consideration of mRNA therapeutics from the early to late phase through interactive sessions and discussions.
Learn from prominent experts why producing LNPs with appropriate diameters and PDI remains a barrier in mRNA delivery and how to overcome this bottleneck.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
TriLink’s CDMO services offer a range of manufacturing grade products from discovery-grade (RUO) to its customizable intermediate-grade - GMPLink™ to full GMP-grade with scale-up and technology transfer expertise.
KACTUS is a biotechnology company serving global biopharma and diagnostics customers. We focus on commercial protein production for unmet needs in the drug development pipeline, including challenging recombinant proteins such as Claudin 18.2, MHC com
KACTUS is a biotechnology company serving global biopharma and diagnostics customers. We focus on commercial protein production for unmet needs in the drug development pipeline, including challenging recombinant proteins such as Claudin 18.2, MHC complexes, GPCR, CD20, and highly bioactive mRNA capp
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.